Results 121 to 130 of about 5,052,436 (221)

[Thrombolytic agent].

Nihon rinsho. Japanese journal of clinical medicine, 2016
K. Harada
semanticscholar   +1 more source

Door to Needle Time in Acute Myocardial Infarction Patients

Journal of Rawalpindi Medical College, 2017
To determine the current door-to-needle time for the administration of fibrinolytics for acute myocardial infarction (AMI) in emergency room. Methods: In this cross sectional study patients presenting with acute myocardial infarction (AMI) were included.
Muhammad Usman
doaj  

SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.

Brain Research, 2014
Akira Ito, K. Niizuma, H. Shimizu, M. Fujimura, Keiji Hasumi, T. Tominaga   +5 more
semanticscholar   +1 more source

Pulmonary alveolar hemorrhage following thrombolytic therapy

, 2017
Santhosh Narayanan,1 NK Thulaseedharan,1 Gomathy Subramaniam,2 Geetha Panarkandy,1 Narayanan Arathi1 1Department of Medicine, 2Department of Radiodiagnosis, Government Medical College, Kozhikode, Kerala, India Abstract: We report a case of a 58-year-old ...
Subramaniam G, Narayanan S, Panarkandy G, Thulaseedharan NK, Arathi N   +4 more
core  

Thrombolytic Therapy in Acute Stroke

, 2008
SummaryStroke as a cerebral dysfunction is strongly related to obstruction of cerebral perfusion. Thrombolytic agents have dramatic medical effects on reperfusion after cerebral infarction. Thus, early diagnosis and proper use of thrombolytic agents have
Wai-Mau Choi, Chuan-Chuan Liu, I-Fang Liu, Yen-Wei Hsu   +3 more
core   +1 more source

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

New England Journal of Medicine, 1993
R. Gibbons, D. Holmes, G. Reeder, K. Bailey, M. Hopfenspirger, B. Gersh   +5 more
semanticscholar   +1 more source

Data_Sheet_1_Magnetic Iron Sulfide Nanoparticles as Thrombolytic Agents for Magnetocaloric Therapy and Photothermal Therapy of Thrombosis.docx

, 2019
Non-invasive removal of thrombosis is a difficult problem in clinical vascular disease. Herein, we reported magnetic hyperthermia combined photothermal therapy for celiac vein thrombosis using Fe3S4 nanoparticles as thrombolytic agents under the ...
Junle Liu (8069978), Qilong Ren (1469833), Xiaohu Ge (320532), Dapeng Fu (8069975), Heyi Ding (8069981), Jinhui Ding (34659), Xuan Chen (158617)   +6 more
core   +1 more source

Overview of reteplase, a novel thrombolytic agent in Indian Context

, 2015
A. Dasbiswas, J. Hiremath, A. Trailokya
semanticscholar   +1 more source

Streptokinase‐Induced Serum Sickness: A Case Report

Clinical Case Reports
Serum sickness is rare; however, there is a significant hypersensitivity reaction to streptokinase used in different cardiac problems. Treatment often involves discontinuing the offending agent and administering corticosteroids. This case underscores the
Bibek Shrestha, Rebicca Pradhan, Pradeep Shrestha, Sudip Bastakoti   +3 more
doaj   +1 more source

Aggressive Mechanical Clot Disruption and Low-dose Intra-arterial Third-generation Thrombolytic Agent for Ischemic Stroke: A Prospective Study

Neurosurgery, 2002
Adnan I. Qureshi, A. Siddiqui, M. Suri, Stanley H. Kim, Z. Ali, Abutaher M. Yahia, D. Lopes, A. Boulos, A. Ringer, M. Saad, L. Guterman, L. Hopkins   +11 more
semanticscholar   +1 more source